Partnering Webinars

  1. A Turnkey Solution For Clinical Trials In Australia 6/16/2025

    This presentation is centered on Australia's unique value proposition in the global research landscape, emphasizing its ability to deliver high-quality trials with speed and efficiency.

  2. Mastering The Complexities Of Gene Therapy Document Writing 5/20/2025

    Gain the insight and strategic flexibility needed to confidently navigate the unique scientific, regulatory, and documentation challenges of gene therapy development.

  3. Top 3 Tips For Choosing The Right Oncology CRO 5/14/2025

    From complex study designs and evolving regulations to time-sensitive treatment protocols, advancing oncology clinical trials present significant challenges for investigators, sites, and patients.

  4. APAC's Advantage In Oncology Trials: Fast Start, Lower Cost, Global Impact 5/14/2025

    Partnering with Southern Star Research provides access to deep regional expertise, operational excellence, and a proven track record of delivering high-quality clinical trials.

  5. Navigating The Early Oncology Landscape: Market Trends And Insights 5/14/2025

    Explore the evolving landscape of early-phase oncology clinical trials, including strategic insights to empower operations teams in optimizing study design, site selection, and recruitment.

  6. Strategic Considerations For Oncology Trials In A Competitive Landscape 5/14/2025

    By combining strategic foresight with hands-on support, the right partner accelerates oncology trial delivery and broadens access to promising therapies.

  7. Avance Clinical Clinical Leader Solutions Expo May 2025: CRO Services – Oncology 5/14/2025

    This presentation outlines the key success factors driving high-impact oncology drug development, with a focus on translating innovative science into clinically and commercially meaningful outcomes.

  8. The Importance Of Cognitive And Pharmacodynamic Testing During FIH Trials 5/9/2025

    Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.

  9. How To Drive Stronger Sponsor-Site Partnerships 4/25/2025

    Karri Venn of SCRS discussed the value of deep partnerships, referencing a Sanofi initiative (SMILE) that trusted sites with protocol input and offered maximum budgets without negotiation.

  10. How Sites Are Often Evaluated By Sponsors 4/25/2025

    Adam Kinsey described how sponsor-site partnerships at Merck typically start small. Sites are evaluated not only on enrollment but on predictability and communication throughout a study.